Reata Pharmaceuticals, Inc (NASDAQ:RETA) Given Average Recommendation of Moderate Buy by Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $110.86 and last traded at $109.91, with a volume of 82894 shares traded. The stock had previously closed at $109.32. Wall Street Analyst Weigh In RETA has been […]
HighMark Wealth Management LLC grew its holdings in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Free Report) by 119.7% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,269 shares of the company’s stock after purchasing an additional 11,588 shares during the quarter. Reata Pharmaceuticals […]
Reata Pharmaceuticals (NASDAQ:RETA – Free Report) had its target price increased by LADENBURG THALM/SH SH from $104.00 to $122.00 in a research report released on Thursday, The Fly reports. Several other analysts have also commented on the company. SVB Securities upgraded Reata Pharmaceuticals from a market perform rating to an outperform rating and increased their […]
Reata Pharmaceuticals (NASDAQ:RETA – Free Report) had its target price boosted by Barclays from $98.00 to $110.00 in a report released on Wednesday, The Fly reports. A number of other equities research analysts have also issued reports on RETA. Robert W. Baird increased their target price on shares of Reata Pharmaceuticals from $40.00 to $85.00 […]